User:Mr. Ibrahem/Treprostinil

Treprostinil, sold under the brand names Remodulin among others, is a medication used to treat pulmonary arterial hypertension. It is taken by mouth, injected, or inhaled.

Common side effects include headache, nausea, flushing, and pain. Other side effects may include infection, bleeding, and low blood pressure. Safety in pregnancy and breastfeeding is unclear. It is a vasodilator and synthetic analog of prostacyclin.

Treprostinil was approved for medical use in the United States in 2002. In the United States it can only be acquired through a specialty pharmacy. In Europe it was granted orphan designation in 2004. In Canada the injectable formulation cost about 52,000 to 173,000 per year as of 2015. A generic version was approved in 2017.